Public

EQS-News: AdrenoMed Receives FDA Fast Track Designation for Enibarcimab for Treatment of Septic Shock

Retrieved on: 
Wednesday, April 10, 2024
Sepsis, Communication, Patient, Public, Fast Track, Adrenomedullin, Biomarker, Accelerated approval (FDA), Mortality, Septic shock, Death, DPP3, Septic, Medicine, Priority review, Organ dysfunction, Intensive care medicine, CMO, Collection, FDA, Infection, RCI, Food, Pharmaceutical industry

AdrenoMed is now preparing a confirmatory Phase IIb/III clinical trial to confirm the reduced septic shock mortality under enibarcimab treatment employing a precision medicine approach.

Key Points: 
  • AdrenoMed is now preparing a confirmatory Phase IIb/III clinical trial to confirm the reduced septic shock mortality under enibarcimab treatment employing a precision medicine approach.
  • AdrenoMed’s CEO Dr. Richard Jones commented: “We are very pleased that enibarcimab has received Fast Track designation from the FDA, recognizing its potential as an innovative biomarker-guided treatment against septic shock to fill the unmet medical need in this very serious condition with a high death toll.
  • With a mortality rate of 20-30% for sepsis [1] and 30%-50% for septic shock in developed countries, [2] sepsis represents an enormous public health burden and is responsible for almost 20% of all deaths worldwide.
  • Dr. Stephan Witte, CMO of AdrenoMed, said: “We are very confident that the use of enibarcimab in combination with two biomarkers, Adrenomedullin (bio-ADM) and circulating dipeptidyl peptidase 3 (cDPP3), holds the promise to become the first effective targeted treatment against septic shock.

Global Experts from SEPA Call for the Control of Gingivitis Rather than Waiting for Periodontitis to Develop

Retrieved on: 
Monday, April 8, 2024
CASA, Toothpaste, Head, Confusion, Tooth brushing, EFP, Journal of Clinical Periodontology, Patient, Quality of life, Complutense University of Madrid, UCM, Therapy, Dental, Oral hygiene, Etiology, United States of Europe, Risk, Education, Gingivitis, Treatment, Recurrence, Dentistry, Prevalence, Disease, Clinical, White paper, Public, Knowledge, Research, University, Overalls, University College London, Mouthwash, Dentist, Molina Healthcare, Health, Motivation, Incidence, Physician, British Dental Journal, Inflammation, Pharmacist, Plaque, Systematic review, Bleeding, S3, Meta-analysis

SEPA: Limited knowledge among oral health teams of the recommendations and evidence currently available on oral antiseptics (that are clinically proven to be effective) reduces their implementation; therefore, more practical and simple advice is proposed.

Key Points: 
  • This was highlighted at an International Summit of Experts held at the Casa de las Encías in Madrid, Spain, the headquarters of the SEPA Foundation.
  • "Periodontal diseases are prevalent worldwide, affecting hundreds of millions of people," says the meeting coordinator, Dr. Paula Matesanz, vice president of SEPA.
  • As Dr. Iain Chapple summarizes, "It is time for a paradigm shift: we must control gingivitis and not wait until periodontitis develops."
  • J Clin Periodontol 2022 Jun:49 Suppl 24:4-71 (version adapted by SEPA available at https://portal.guiasalud.es/gpc/tratamiento-periodontitis-estadio-iv )
    * Chapple I, Time to take gum disease seriously.

National Veterinary Association Calls on Federal Government to Address Severe Workforce Shortage

Retrieved on: 
Wednesday, March 20, 2024
Health, Attention, MNP, Social change, Federation, Patient, Public, Employment, Mental health, Research, Veterinary medicine, Social Development Canada, Human, Veterinarian, CVMA, Suicidal ideation, Investment, GDP, Parliament Hill, COPS, Animal, MNP LLP, Global News, ESDC

Establishment of a National Testing Centre for Internationally Educated Veterinarians Needed

Key Points: 
  • The veterinary profession in Canada faces pressing challenges that demand immediate attention from the federal government.
  • "Given the severe workforce shortage in our profession, Canada needs a veterinary workforce enhancement program that supports expansion and innovation of clinical teaching, training, and research to develop the next generation of veterinarians in response to societal demands."
  • The workforce shortage poses a significant threat to the veterinary profession and its ability to provide quality care for its patients and clients.
  • The Canadian Veterinary Medical Association is the national and international voice for Canada's veterinarians, providing leadership and advocacy for veterinary medicine.

ArcStone Securities and Investments Corp. Announces Strategic Collaboration with Kingswood US to Deliver Expanded Capital Markets Advisory Services Establishing a Presence in the Canadian Capital Markets

Retrieved on: 
Wednesday, March 13, 2024
Private placement, Culture, Public, Growth, Philosophy, Partnership, Executive officer, Metal, IPO, Equity, TSX, Investment, CBOE, Mining

This collaboration will enable clients to benefit from an expanded suite of services designed to drive value creation and advance their strategic objectives.

Key Points: 
  • This collaboration will enable clients to benefit from an expanded suite of services designed to drive value creation and advance their strategic objectives.
  • Collectively, ArcStone and Kingswood bring together a seasoned team in Canada and the US with a shared commitment to integrity and client success.
  • This marks a significant milestone for ArcStone and Kingswood in its unwavering commitment to providing comprehensive capital market solutions and strategic advisory services across a north-south nexus.
  • Pre-Initial Public Offering (Pre-IPO) Strategy: Initial Public Offering (IPO) Execution, Debt Capital Markets Access, Private Placements, and Private Capital Advisory.

Moderna Achieves Positive Interim Results from Phase 3 Trial of Next-Generation COVID-19 Vaccine

Retrieved on: 
Tuesday, March 26, 2024
COVID-19 vaccine, Risk, Headache, COVID-19, Ageing, Public, Vaccine, MRNA, Messenger, Chills, SARS-CoV-2, Myalgia, Clinical trial, Safety, Omicron, Fatigue

"We are excited to announce our fourth infectious disease vaccine program with positive Phase 3 data, further validating our robust mRNA platform," said Stephane Bancel, Chief Executive Officer of Moderna.

Key Points: 
  • "We are excited to announce our fourth infectious disease vaccine program with positive Phase 3 data, further validating our robust mRNA platform," said Stephane Bancel, Chief Executive Officer of Moderna.
  • "mRNA-1283 is a critical component of our combination vaccine against flu and COVID-19, mRNA-1083, and this milestone gives us confidence in our ability to bring this much needed vaccine to market."
  • In the NextCOVE (NCT05815498) Phase 3 pivotal trial, mRNA-1283 was shown to elicit a higher immune response against both the Omicron BA.4/BA.5 and original virus strains of SARS-CoV-2, compared to mRNA-1273.222.
  • A detailed analysis of the Phase 3 clinical trial data for mRNA-1283 will be shared at the Company's Vaccines Day event on March 27 and presented at upcoming scientific conferences.

Recce Pharmaceuticals Selected by UK Government Innovation Agency to Participate in AMR Mission 2024

Retrieved on: 
Wednesday, April 10, 2024
Organization, Growth, Global health, Public, Research, ASX, RCE, Local government, United, AMR, Ecosystem, Innovate UK, Government, Innovation

Professor Dame Sally Davies, former England Chief Medical Officer, hosting a reception with selected organizations offering Recce strategic partnering opportunities in the AMR space

Key Points: 
  • Professor Dame Sally Davies, former England Chief Medical Officer, hosting a reception with selected organizations offering Recce strategic partnering opportunities in the AMR space
    SYDNEY, Australia, April 09, 2024 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q), (the Company), the Company developing a new class of synthetic anti-infectives, today announced its selection by the United Kingdom’s (UK) Government Innovation Agency (Innovate UK) to partake in the prestigious UK Antimicrobial Resistance (AMR) Inward Mission 2024.
  • “We are thrilled by the opportunity to collaborate with the UK’s leading AMR experts and institutions and thank the UK government for their support,” said James Graham, Chief Executive Officer of Recce Pharmaceuticals.
  • The UK AMR Inward Mission 2024 will host a comprehensive program, including partnering sessions, visits to world-class AMR infrastructure, and interactions with key opinion leaders.
  • The selection of Recce for the UK AMR Inward Mission signifies an important geographic opportunity in its global strategy, particularly in establishing a foothold in the UK’s vibrant AMR research and development ecosystem.

Cummins, Inc. Long-Term Shareholder Announcement: Johnson Fistel, LLP Encourages Investors to Reach Out For More Information

Retrieved on: 
Tuesday, April 9, 2024
Environment, SAN, Public, LLP, DOJ, CMI, EPA, Justice

If you have continuously owned Cummins Inc. (NYSE: CMI) shares, you have certain legal rights as a shareholder.

Key Points: 
  • If you have continuously owned Cummins Inc. (NYSE: CMI) shares, you have certain legal rights as a shareholder.
  • The company agreed to pay a substantial $1.675 billion civil penalty for its actions.
  • California Attorney General Rob Bonta emphasized that Cummins knowingly evaded state emissions tests and requirements, causing harm to public health and the environment.
  • This penalty represents the largest amount ever recovered by the DOJ under the Clean Air Act and is the second-largest environmental penalty secured.

Verizon powers digital government for the Commonwealth of Virginia

Retrieved on: 
Tuesday, April 9, 2024
Organization, Verizon Communications, Public, Government, Private, Pressure, Education, Communication, Partnership, Public sector, Cisco, Workload, Commonwealth, Cryptocurrency

This milestone accomplishment is a result of the partnership between Verizon and the Commonwealth, where the focus is on further enabling digital government through enhanced network performance.

Key Points: 
  • This milestone accomplishment is a result of the partnership between Verizon and the Commonwealth, where the focus is on further enabling digital government through enhanced network performance.
  • Supported by Verizon's team of managed service experts, this solution eases the workload of government agencies and enhances business growth.
  • Enhanced network performance: The implementation of Managed SD WAN improves network performance, allowing government agencies to operate more efficiently and securely.
  • “We are thrilled to partner with the Commonwealth of Virginia, and applaud them for prioritizing modernization efforts,” said Patty Roze, Vice President for Public Sector (State, Local and Education) at Verizon.

Carahsoft Named Google Cloud’s Global Public Sector Partner of the Year for 2024

Retrieved on: 
Tuesday, April 9, 2024
Cloud, Google Cloud, Conference, Public, ISV, Trust (social science), Government agency, Public sector, Carahsoft, Ecosystem, FedRAMP, Marketing, Corporation, Network equipment provider

RESTON, Va., April 09, 2024 (GLOBE NEWSWIRE) -- Carahsoft Technology Corp. , The Trusted Government IT Solutions Provider®, today announced that it has received the 2024 Google Cloud Global Public Sector Partner of the Year Award.

Key Points: 
  • RESTON, Va., April 09, 2024 (GLOBE NEWSWIRE) -- Carahsoft Technology Corp. , The Trusted Government IT Solutions Provider®, today announced that it has received the 2024 Google Cloud Global Public Sector Partner of the Year Award.
  • The award was announced on the Google Cloud blog , and at the 2024 Google Cloud Next Conference , and highlights Carahsoft’s exceptional dedication to fostering customer relationships and cultivating a robust partner ecosystem crucial for Google Cloud’s success in the Public Sector.
  • “We're proud to announce Carahsoft as a 2024 Google Cloud Partner Award winner and recognize their achievements enabling customer success from the past year.”
    As Google Cloud’s Public Sector Distributor since 2015, Carahsoft remains committed to enhancing Google Cloud’s presence within the Public Sector through its multifaceted approach.
  • “Carahsoft is honored to receive Google Cloud’s 2024 Global Public Sector Partner of the Year Award,” said Terry Drinkwine, Vice President at Carahsoft.

Lava for Good Podcasts Garners Webby Nominations for 'The War on Drugs' and Honors for 'Earwitness'

Retrieved on: 
Thursday, April 4, 2024
War on Drugs, Webby Awards, Depression, Music, Partnership, Name, Public, Dignity, Humour, Human, Season, Season 2, Justice, War, Good, Pain management, Legislation, Sport, Miscarriage, Public service, PTSD, Entertainment

NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Lava for Good Podcasts is honored by the latest accolades in the digital world.

Key Points: 
  • NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Lava for Good Podcasts is honored by the latest accolades in the digital world.
  • The latest recognition for The War on Drugs is particularly timely, as Lava for Good has commenced production of Season 2 for release this fall.
  • These nominations and honors add to Lava for Good’s long list of accolades, including past recognition at the Webby Awards, Ambie Awards, Signal Awards, and iHeartPodcast Awards.
  • For more information on The War on Drugs, Earwitness, and other Lava for Good podcasts, visit www.lavaforgood.com or find them on all popular podcast platforms.